Golden Meds Revenue and Competitors
Estimated Revenue & Valuation
- Golden Meds's estimated annual revenue is currently $4M per year.
- Golden Meds's estimated revenue per employee is $158,900
Employee Data
- Golden Meds has 25 Employees.
- Golden Meds grew their employee count by 9% last year.
Golden Meds's People
Name | Title | Email/Phone |
---|
Golden Meds Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.7M | 113 | 8% | N/A | N/A |
#2 | $1414.8M | 4452 | 5% | N/A | N/A |
#3 | $6M | 33 | 0% | N/A | N/A |
#4 | $8.7M | 48 | -9% | N/A | N/A |
#5 | $170.9M | 178 | 6% | $247.8M | N/A |
#6 | $12.7M | 62 | 32% | N/A | N/A |
#7 | $74.2M | 297 | 26% | N/A | N/A |
#8 | $0.1M | 3 | 0% | N/A | N/A |
#9 | $1061.5M | 3340 | 3% | N/A | N/A |
#10 | $6.9M | 38 | 15% | N/A | N/A |
What Is Golden Meds?
Established in 2009, Golden Meds Dispensaries has been a staple in the cannabis community and serves as a resource for recreational and medical cannabis patients alike. Being an intrinsic part of the Denver community for as long as we have has given us the opportunity to blossom and grow with the Denver community. Relationships matter most. Embracing inclusion and promoting diversity has cultivated deep-rooted relationships within our dispensaries and neighborhoods.
keywords:N/AN/A
Total Funding
25
Number of Employees
$4M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Golden Meds News
When Golden Meds was burglarized last summer, thieves broke through a glass window and kicked open the wooden door that protected the safe. She...
Officials said the mother inside the duplex left to go to Golden Express, a corner store about a block away, leaving all seven children.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 25 | 0% | $0.41M |
#2 | $2.5M | 25 | N/A | N/A |
#3 | $2.9M | 25 | N/A | N/A |
#4 | $2.5M | 25 | N/A | N/A |
#5 | $3.5M | 25 | -7% | N/A |